|
|
Article: Orchid BioSciences To Apply SNP Analysis To WTC Effort.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Staff Writer
Almost a year after the Sept. 11 tragedy, more than half of the victims at New York's World Trade Center remain unidentified.
While about 49 percent of the nearly 3,000 killed as a result of the terrorist attacks on the twin towers have been identified using forensic techniques including DNA analysis, the effort remains far from complete.
Enter Orchid BioSciences Inc., which was awarded a contract by New York's chief medical examiner to continue the process. Though DNA in more than half of the remains is so damaged or degraded that it has been rendered unidentifiable to date, Orchid will use its single nucleotide polymorphism (SNP) ...